Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years

NCT03179423 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 1

Interventions

DRUG: GNbAC1
DRUG: Placebo

Sponsor

GeNeuro Australia PTY Ltd

Collaborators

[object Object]